Krasner Alan Seth 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Oct 19, 2023
Insider Transaction Report
Form 4
Krasner Alan Seth
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-10-17$30.00/sh−7,000$210,000→ 43,210 total - Exercise/Conversion
Common Stock
2023-10-17$12.01/sh+7,000$84,070→ 50,210 total - Exercise/Conversion
Non-qualified stock option (Right to Buy)
2023-10-17−7,000→ 153,473 totalExercise: $12.01Exp: 2028-06-15→ Common Stock (7,000 underlying)
Footnotes (2)
- [F1]Includes 909 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
- [F2]25% of the shares subject to the option vest on June 16, 2019, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. The stock options are also subject to accelerated vesting as set forth in the employment agreement between the Issuer and the Reporting Person.